Burcon Nutrascience AI Stock Analysis
Want to see TSE:BU full AI Analyst Report?
Burcon Nutrascience (BU) AI Stock Analysis
Burcon Nutrascience
(TSX:BU)
The overall score is severely pressured by the company's distressed financial state and bearish technical trends. The balance sheet is insolvent, cash burn is high, and the stock is in a sustained downtrend. The primary support comes from an optimistic earnings call, where management outlined a credible path to positive cash flow driven by a strong customer pipeline and production scaling. However, this forward-looking optimism is heavily discounted by the current financial reality and weak market momentum.
Burcon Nutrascience (BU) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 6.99M
- Dividend Yield
- ―
- Average Volume (3M)
- 7,943
- Price to Earnings (P/E)
- -0.7
- Beta (1Y)
- 0.57
- Revenue Growth
- 383.05%
- EPS Growth
- -14.16%
- Country
- Canada
- Employees
- 14
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Burcon Nutrascience Business Overview & Revenue Model
Company Description
Burcon NutraScience Corporation, along with its associated entities, is a Canadian enterprise specializing in the development and commercialization of plant-derived proteins and functional ingredients for the food and beverage sectors. Its extensive...
Burcon Nutrascience Earnings Call Summary
The call was strongly optimistic, supported by nearly threefold year-over-year revenue growth, more than 40 buying customers, 209 active projects, improving production performance, insider financing support and expectations for significant Q3 growth, positive cash flow and a $10-plus million run rate in calendar 2027. The main negatives were an 18% sequential revenue decline, second-quarter infrastructure-related production constraints, a temporary slowdown in new customer onboarding, an ongoing operating loss and an external financing raise that remains in progress. Highlights significantly outweighed the lowlights.
Q2-2027 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects to see significant sequential quarter-over-quarter growth in Q3 and described a path to a $10-plus million run rate, meaningful operating leverage and positive cash flow into calendar 2027, with positive cash flow inside of calendar 2027 and 2027 a breakout year; 1/3 of growth is expected from existing customers and existing products, 1/3 most likely from existing customers launching a new product, a new flavor, a new SKU, and the last part from new customers with new projects, while 26 of 209 active projects are past the pallet order stage and are expected to drive near-term growth in early to mid-2027. The company is currently running a 5-day 24-hour a day operation and plans to move to a 7-day, 24-hour a day operation in the coming months.
Burcon Nutrascience Financial Statement Overview
Summary
Financial health is critically weak. The company is insolvent with negative equity (-$13.2M) and deeply negative gross margins (-239%). Despite 21.4% revenue growth, the $15M net loss and $9.4M negative free cash flow indicate a cash-intensive, unprofitable operation with no near-term path to self-sufficiency.
Income Statement
8Very NegativeBalance Sheet
5Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.88M | 2.26M | 381.40K | 184.36K | 363.91K | 171.47K |
| Gross Profit | -9.30M | -8.02M | -870.76K | 184.36K | 363.91K | 171.47K |
| EBITDA | -9.54M | -9.85M | -6.86M | -6.23M | -18.90M | -9.92M |
| Net Income | -15.03M | -14.25M | -8.26M | -7.45M | -25.36M | -10.26M |
Balance Sheet | ||||||
| Total Assets | 22.89M | 22.99M | 30.66M | 12.91M | 9.90M | 29.35M |
| Cash, Cash Equivalents and Short-Term Investments | 998.88K | 950.53K | 7.28M | 4.20M | 1.46M | 7.00M |
| Total Debt | 32.50M | 24.42M | 22.40M | 6.67M | 5.17M | 73.14K |
| Total Liabilities | 36.05M | 28.79M | 23.71M | 7.76M | 5.76M | 1.10M |
| Stockholders Equity | -13.16M | -5.80M | 6.94M | 5.15M | 4.14M | 28.25M |
Cash Flow | ||||||
| Free Cash Flow | -9.41M | -10.12M | -5.82M | -5.90M | -6.38M | -7.18M |
| Operating Cash Flow | -8.93M | -9.16M | -5.51M | -5.78M | -6.02M | -5.91M |
| Investing Cash Flow | -415.65K | -883.39K | -1.66M | -39.49K | -4.43M | -1.23M |
| Financing Cash Flow | 8.53M | 3.85M | 10.23M | 8.56M | 4.90M | 174.08K |
Burcon Nutrascience Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BU, the sentiment is Negative. The current price of 0.84 is below the 20-day moving average (MA) of 0.94, below the 50-day MA of 1.19, and below the 200-day MA of 1.79, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 37.98 is Neutral, neither overbought nor oversold. The STOCH value of 13.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:BU.
Burcon Nutrascience Peers Comparison
Overall Rating
TSE:NPRA49Neutral
TSE:BU46Neutral
TSE:CULT38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 49Neutral | CAD 37.20M | -25.66 | 30.14% | ― | 32.91% | 55.73% | |
| 46Neutral | CAD 10.79M | -0.71 | 197.12% | ― | 383.05% | -14.16% | |
| 38Underperform | CAD 789.24K | -0.46 | -9999.00% | ― | 3288.96% | 50.66% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:BU | Burcon Nutrascience Corporation | 0.84 | -0.86 | -50.59% | |
| TSE:DTEA | Davidstea Inc. | 1.10 | 0.17 | 18.28% | |
| TSE:NPRA | Nepra Foods, Inc. | 0.29 | 0.17 | 152.17% | |
| TSE:CULT | Cult Food Science Corp. | 0.32 | -0.18 | -36.00% |
Burcon Nutrascience Corporate Events
Burcon Secures Shareholder Backing and Financing as It Resets Commercial Guidance
PositiveBurcon NutraScience, a plant-based protein technology company serving food and beverage manufacturers with pea, fava and canola protein ingredients, is deepening its focus on scaling reliable production capacity. The company aims to use its proprieta...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 20, 2026
